Thromboembolic events and anti-tumor necrosis factor therapies

International Immunopharmacology

Volumn 14, Issue 4, 2012, Pages 444-445

  Masson, P L ^a  

^a DE DUVE INSTITUTE   (Belgium)

Author keywords

Interferon ; Lupus like syndrome; Thromboembolism; TNF antagonist

Indexed keywords

ABATACEPT; ADALIMUMAB; ALPHA INTERFERON; BETA2 GLYCOPROTEIN 1 ANTIBODY; CERTOLIZUMAB PEGOL; CHIMERIC ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; ETANERCEPT; GOLIMUMAB; HYBRID PROTEIN; INFLIXIMAB; MYXOVIRUS RESISTANCE PROTEIN A; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TUMOR NECROSIS FACTOR INHIBITOR;

ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; IMMUNOGENICITY; INTERSTITIAL LUNG DISEASE; OPTIC NEURITIS; PRIORITY JOURNAL; PSORIASIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; VASCULITIS;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; AUTOANTIBODIES; HUMANS; IMMUNOGLOBULIN G; RECEPTORS, TUMOR NECROSIS FACTOR; THROMBOEMBOLISM;

EID: 84866999998     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.08.018     Document Type: Article

References (10)

1. N. Petitpain, N. Gambier, D. Wahl, I. Chary-Valckenaere, D. Loeuille, and P. Gillet French Network of Pharmacovigilance Centers. Arterial and venous thromboembolic events during anti-TNF therapy: a study of 85 spontaneous reports in the period 2000-2006 Biomed Mater Eng 19 2009 355 364
2. A. Makol, M. Grover, C. Guggenheim, and H. Hassouna Etanercept and venous thromboembolism: a case series J Med Case Reports 4 2010 12
3. L.A. Korswagen, G.M. Bartelds, C.L. Krieckaert, F. Turkstra, M.T. Nurmohamed, and D. van Schaardenburg Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies. A case series and cohort study Arthritis Rheum 63 2011 877 883
4. M. Ramos-Casals, Roberto-Perez-Alvarez, C. Diaz-Lagares, M.J. Cuadrado, M.A. Khamashta, and BIOGEAS Study Group Autoimmune diseases induced by biological agents. A double-edged sword? Autoimmun Rev 9 2010 188 193
5. A.K. Palucka, J.P. Blanck, L. Bennett, V. Pascual, and J. Banchereau Cross-regulation of TNF and IFN-α in autoimmune diseases Proc Natl Acad Sci U S A 102 2005 3372
6. D.C. Balderramo, O. García, J. Colmenero, G. Espinosa, X. Forns, and P. Ginès Antiphospholipid syndrome during pegylated interferon-α-2a therapy for chronic hepatitis C Dig Liver Dis 41 2009 e4 e7
7. T.L. Ortel Thrombosis and the antiphospholipid syndrome Hematology Am Soc Hematol Educ Program 2005 462 468
8. C.C. Mok, S.S. Tang, C.H. To, and M. Petri Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups Arthritis Rheum 52 2005 2774 2782
9. J. Seneschal, B. Milpied, B. Vergier, S. Lepreux, T. Schaeverbeke, and A. Taïeb Cytokine imbalance with increased production of interferon-α in psoriasiform eruptions associated with antitumour necrosis factor-α treatments Br J Dermatol 161 2009 1081 1088
10. M. Feldmann, and S.R. Maini Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics Immunol Rev 223 2008 7 19